BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

Saturday, 4 July 2020

Clyra Medical Technologies- work with Clyraguard and inactivation of SARS CoV-2 Published

RESEARCH ARTICLE

In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation

[version 1; peer review: awaiting peer review]

Emily Mantlo1, Tanya Rhodes2, Jenny Boutros3, Laura Patterson-Fortin3, Alex Evans
4, Slobodan Paessler1

Link to Publication Here

Saturday, 4 July 2020

Clyra Medical Technologies- work with Clyraguard and inactivation of SARS CoV-2 Published

In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation

No comments:

Post a Comment